{
    "address1": "9 Cedarbrook Drive",
    "city": "Cranbury",
    "state": "NJ",
    "zip": "08512",
    "country": "United States",
    "phone": "609 659 8001",
    "website": "https://rocketpharma.com",
    "industry": "Biotechnology",
    "sector": "Healthcare",
    "longBusinessSummary": "Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energ\u00e9ticas, Medioambientales y Tecnol\u00f3gicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.",
    "fullTimeEmployees": 240,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Dr. Gaurav D. Shah M.D.",
            "age": 47,
            "title": "CEO & Director",
            "yearBorn": 1975,
            "fiscalYear": 2022,
            "totalPay": 1053223,
            "exercisedValue": 0,
            "unexercisedValue": 1905557
        },
        {
            "maxAge": 1,
            "name": "Ms. Kinnari  Patel M.B.A., MBA, Pharm.D., PharmD",
            "age": 43,
            "title": "Pres & COO",
            "yearBorn": 1979,
            "fiscalYear": 2022,
            "totalPay": 849928,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. John C. Militello CPA, CPA",
            "age": 49,
            "title": "VP, Sr. Controller, Treasurer, Principal Accounting Officer & Interim Principal Financial Officer",
            "yearBorn": 1973,
            "fiscalYear": 2022,
            "totalPay": 501421,
            "exercisedValue": 0,
            "unexercisedValue": 3457
        },
        {
            "maxAge": 1,
            "name": "Mr. Mayo  Pujols",
            "age": 53,
            "title": "Chief Technical Officer & Exec. VP",
            "yearBorn": 1969,
            "fiscalYear": 2022,
            "totalPay": 649711,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Raj  Prabhakar M.B.A.",
            "age": 48,
            "title": "Sr. VP & Chief Bus. Officer",
            "yearBorn": 1974,
            "fiscalYear": 2022,
            "totalPay": 619127,
            "exercisedValue": 0,
            "unexercisedValue": 55650
        },
        {
            "maxAge": 1,
            "name": "Mr. Martin Louis Wilson J.D.",
            "age": 46,
            "title": "Gen. Counsel, Chief Compliance Officer & Sr. VP",
            "yearBorn": 1976,
            "fiscalYear": 2021,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Kevin  Giordano",
            "title": "Director of Corp. Communications",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Isabel  Carmona J.D.",
            "title": "Sr. VP & Chief HR Officer",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Jonathan  Schwartz M.D.",
            "age": 57,
            "title": "Chief Gene Therapy Officer & Sr. VP of Clinical Devel.",
            "yearBorn": 1965,
            "fiscalYear": 2021,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Gayatri R. Rao J.D., M.D.",
            "title": "Chief Devel. Officer of LVV & Sr. VP",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 4,
    "boardRisk": 9,
    "compensationRisk": 7,
    "shareHolderRightsRisk": 6,
    "overallRisk": 7,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 15.88,
    "open": 15.87,
    "dayLow": 15.48,
    "dayHigh": 15.9,
    "regularMarketPreviousClose": 15.88,
    "regularMarketOpen": 15.87,
    "regularMarketDayLow": 15.48,
    "regularMarketDayHigh": 15.9,
    "payoutRatio": 0.0,
    "beta": 1.15491,
    "forwardPE": -6.331984,
    "volume": 391702,
    "regularMarketVolume": 391702,
    "averageVolume": 604154,
    "averageVolume10days": 383840,
    "averageDailyVolume10Day": 383840,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 800,
    "askSize": 800,
    "marketCap": 1259418880,
    "fiftyTwoWeekLow": 11.78,
    "fiftyTwoWeekHigh": 24.53,
    "fiftyDayAverage": 17.452,
    "twoHundredDayAverage": 19.2194,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 977765312,
    "profitMargins": 0.0,
    "floatShares": 56421019,
    "sharesOutstanding": 80525504,
    "sharesShort": 7717450,
    "sharesShortPriorMonth": 7974279,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.0958,
    "heldPercentInsiders": 0.03756,
    "heldPercentInstitutions": 1.00175,
    "shortRatio": 13.37,
    "shortPercentOfFloat": 0.1297,
    "bookValue": 5.005,
    "priceToBook": 3.124875,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "netIncomeToCommon": -248515008,
    "trailingEps": -3.18,
    "forwardEps": -2.47,
    "pegRatio": 0.02,
    "lastSplitFactor": "1:4",
    "lastSplitDate": 1515110400,
    "enterpriseToEbitda": -3.856,
    "exchange": "NGM",
    "quoteType": "EQUITY",
    "symbol": "RCKT",
    "underlyingSymbol": "RCKT",
    "shortName": "Rocket Pharmaceuticals, Inc.",
    "longName": "Rocket Pharmaceuticals, Inc.",
    "firstTradeDateEpochUtc": 1424269800,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 15.64,
    "targetHighPrice": 75.0,
    "targetLowPrice": 39.0,
    "targetMeanPrice": 52.6,
    "targetMedianPrice": 48.5,
    "recommendationMean": 1.6,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 10,
    "totalCash": 307040000,
    "totalCashPerShare": 3.813,
    "ebitda": -253559008,
    "totalDebt": 25386000,
    "quickRatio": 8.94,
    "currentRatio": 9.086,
    "debtToEquity": 6.3,
    "returnOnAssets": -0.36091,
    "returnOnEquity": -0.62861997,
    "freeCashflow": -120857248,
    "operatingCashflow": -208308992,
    "grossMargins": 0.0,
    "ebitdaMargins": 0.0,
    "operatingMargins": 0.0,
    "financialCurrency": "USD",
    "trailingPegRatio": null,
    "parent_etfs": [
        "GNOM"
    ]
}